Top Markets
#1 Threshold Network Threshold Network +62.22%
#2 TENDIES TENDIES +59.58%
#3 Cash Cat Cash Cat +20.67%
#4 OSK OSK +15.99%
#5 Magma Finance Magma Finance +13.45%
#6 Ape and Pepe Ape and Pepe +12.62%
#7 Kite Kite +11.97%
#8 Falcon Finance Falcon Finance +11.18%
#9 Asteroid Shiba Asteroid Shiba +10.17%
#10 Maple Finance Maple Finance +10.08%
Coin of the day
Threshold Network Threshold Network
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Rang în acțiuni #17292
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Preț acțiune
$1.35
Ultima sincronizare: 2026-09-01
Capitalizare de piață
$249.21M
Schimbare (1 zi)
1.13%
Schimbare (1 an)
-22.70%
Țară
US
Tranzacționează Neumora Therapeutics, Inc. Common Stock (NMRA)

Categorie

Healthcare
Venituri pentru Neumora Therapeutics, Inc. Common Stock (NMRA)
Venituri în Sep 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Neumora Therapeutics, Inc. Common Stock, venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Neumora Therapeutics, Inc. Common Stock din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH